Full-Time

Manager – Field Application Scientist

Ngs

Posted on 1/15/2025

Twist Bioscience

Twist Bioscience

1,001-5,000 employees

Produces synthetic DNA for biotechnology applications

No salary listed

Senior

Remote in USA

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • 5+ years of technical and commercial experience working with NGS products.
  • Prior in-depth and hands-on technical experience and understanding of NGS applications, methods, implementation, process, and workflow required.
  • MS/PhD in Molecular Biology, Biochemistry or related field.
  • Excellent communication and interpersonal skills for customer interaction and cross-functional collaboration.
  • Advanced technical knowledge of NGS applications, methods, and instrumentation.
  • High self-motivation and must have demonstrated ability to work in a collaborative team environment.
  • Excellent verbal and written communication skills.
  • Ability to travel up to 50% of the time to support team and customer needs.
Responsibilities
  • Support the FAS team by coordinating and prioritizing field team deployment including presales support, trainings, troubleshooting and shows/conferences;
  • Recruit, train, and mentor a team of NGS Field Applications Scientists regarding Twist’s current and upcoming NGS and targeted enrichment (TE) product portfolio;
  • Establish performance metrics and conduct regular evaluations to ensure team excellence.
  • Foster a culture of collaboration, professional growth, and technical excellence.
  • Manage team schedules, ensuring efficient deployment to meet customer needs.
  • Oversee the FAS team's delivery of on-site and remote technical support, troubleshooting, and training to customers using NGS platforms and workflows.
  • Ensure the team provides tailored solutions for diverse customer applications, including DNA, RNA, and epigenetics workflows.
  • Act as an escalation point for complex technical issues, coordinating with internal R&D and support teams as necessary.
  • Working with marketing teams to identify customer facing collateral opportunities and acting as a liaison between groups (technotes, webinars)
  • Work with outside vendors (sequencing, automation, reagent) to cross functionally support troubleshooting and customer requests
  • Work with marketing and product development teams to provide customer feedback and contribute to new product strategies.
  • Develop and implement technical training materials and protocols for the FAS team and customers.
  • Track and report key performance indicators (KPIs) related to team activities, such as response times, customer satisfaction, and issue resolution.
  • Manage budgets and resources for team operations, including travel and other needs.
  • Ensure compliance with company policies and quality standards in all interactions.
Desired Qualifications
  • Prior managerial and/or supervisory experience
  • Cross functional team work
  • Synthetic biology knowledge a plus
  • Automation knowledge and support is a plus
  • Experience of customer support and use of CRM system a plus.

Twist Bioscience specializes in the synthesis of synthetic DNA, which is essential for various applications in biotechnology, pharmaceuticals, and research. The company produces high-quality DNA sequences that clients, including academic institutions and pharmaceutical companies, use for drug development, disease diagnosis, and genetic research. Twist Bioscience differentiates itself by offering competitive pricing and a proprietary platform that enables quick and accurate DNA production. This platform uses an algorithm to assess the feasibility of synthesizing DNA sequences, providing instant feedback to customers. Their product range includes genes, oligo pools, variant libraries, and tools for SARS-CoV-2, along with DNA data storage and next-generation sequencing services. The company's goal is to be a leading supplier in the synthetic biology market, rapidly providing complex DNA sequences to support scientific research and advancements in personalized medicine.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

South San Francisco, California

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Absci enhances capabilities in AI-driven antibody discovery.
  • Partnership with MedGenome positions them as a key player in precision medicine.
  • Launch of CHO Express Antibodies expands their market share in antibody production.

What critics are saying

  • Increased competition from companies like Ginkgo Bioworks could impact market share.
  • Dependency on AI technologies may pose risks if not managed properly.
  • New CIO appointment may lead to transitional challenges in IT strategy and operations.

What makes Twist Bioscience unique

  • Twist Bioscience uses a unique silicon-based DNA synthesis platform for precision and scale.
  • They offer high-quality DNA sequences at competitive prices, attracting diverse clients.
  • Their proprietary platform provides instant feedback on DNA sequence synthesis feasibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Life Insurance

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-1%
TipRanks
Nov 26th, 2024
Twist Bioscience named a Best Idea for 2025 at TD Cowen

Twist Bioscience named a Best Idea for 2025 at TD Cowen.

SynBioBeta
Oct 31st, 2024
Absci and Twist Bioscience Team Up to Redefine Antibody Discovery with AI

Absci, a pioneer in generative AI-driven drug discovery, and Twist Bioscience, a leader in high-quality synthetic DNA production through its silicon platform, have announced an innovative collaboration to create a novel therapeutic antibody using generative AI.

Investing.com
Oct 25th, 2024
Twist Bioscience president sells $97,428 in stock

In other recent news, Twist Bioscience has secured a $15 million capital boost from a new financial agreement with XOMA Royalty Corporation.

Bakersfield.com
Oct 22nd, 2024
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has entered into a royalty purchase agreement with XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator.

Stock Titan
Oct 15th, 2024
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer

SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mike Fero, Ph.D., as chief information officer.

INACTIVE